Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
In combination with T
3
suppression test: Administration of triiodothyronine suppresses RAIU by >50% in the normal person but not in patients with Graves disease or toxic nodules; shows autonomy of TSH secretion. Infrequently used
Interpretation
Increased In
Graves disease (diffuse toxic goiter)
Plummer disease (toxic multinodular goiter)
Toxic adenoma (uninodular goiter)
Thyroiditis (early Hashimoto; recovery stage of subacute thyroiditis)
TSH excess
TSH administration
TSH production by pituitary tumor (TSH >4 μU/mL) or other neoplasm
Defective thyroid hormone synthesis
Human chorionic gonadotropin–mediated hyperthyroidism (e.g., choriocarcinoma, hydatidiform mole, embryonal carcinoma of the testis, hyperemesis gravidarum)
Decreased In
Hypothyroidism (tertiary, secondary, late primary)
Thyroiditis (late Hashimoto; active stage of subacute thyroiditis; RAIU does not usually respond to TSH administration)